Susquehanna International Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,600
Closed -$342K 14240
2022
Q4
$342K Buy
+30,600
New +$297K ﹤0.01% 8782
2022
Q1
Sell
-13,900
Closed -$254K 14401
2021
Q4
$254K Buy
+13,900
New +$176K ﹤0.01% 10900

Other funds holding OYST

Susquehanna International Group's OYST Position: Q1 2023 in Review

Susquehanna International Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 108,443 shares — an estimated $1.21M sold.

Susquehanna International Group first reported a position in OYST in Q2 2021 and held it in 5 quarters. The position peaked at $1.21M in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Susquehanna International Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 108,443 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1.21M.
  • Susquehanna International Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Susquehanna International Group's Oyster Point Pharma, Inc. Common Stock position peaked at $1.21M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.